Established in 1991 Euromedic is now one of the largest public-private partnership healthcare investors and operators in Europe. The company now operates over 171 centres across 15 countries, and specialises in imaging, dialysis, oncology and pathology services.
In September 2008, Merrill Lynch, Ares Life Sciences, Montagu Private Equity became the majority shareholders in Euromedic. The shareholders of Euromedic are among the largest Private Equity groups in the world.
Merrill Lynch Global Private Equity (MLGPE)is the private equity arm of Merrill Lynch & Co., Inc. Merrill Lynch & Co., Inc. is one of the world's leading wealth management, capital markets and advisory companies, with offices in 40 countries and territories and total client assets of approximately $1.6 trillion. As an investment bank, it is a leading global trader and underwriter of securities and derivatives across a broad range of asset classes and serves as a strategic advisor to corporations, governments, institutions and individuals worldwide. Merrill Lynch owns approximately half of Black Rock, one of the world's largest publicly traded investment management companies, with more than $1 trillion in assets under management.
MLGPE makes investments globally, with a primary emphasis on the world's largest economies, including the United States, Europe, Japan, China, India, Latin America and Australia, taking a multi-sector approach to identifying attractive investment opportunities. The company targets investments in high quality, established companies that are recognized brands with industry or regional leadership, defensible market positions, strong cash flow characteristics, and solid, experienced management, combining comprehensive regional and industry-based in-depth analyses with global approval and management processes. For more information on Merrill Lynch and on MLGPE, please visit www.ml.com.
Ares Life Sciences (ALS) is a fund based in Jersey with offices in Switzerland and is focusing its investment activities in the life sciences sector: biotechnology, pharmaceuticals, medical technology and healthcare services. ALS is evaluating and investing in opportunities in all parts of the world with special emphasis on Europe. Ernesto Bertarelli, former Chief executive officer and principal shareholder of Serono SA, is the major sponsor of the fund. ALS is managed by a team of former executives of the pharmaceutical industry with cumulated experience in the life science sector of more than 65 years, their global experience and successful track records scanning the full functional spectrum from R&D to sales.
Montagu Private Equity LLP Montagu is a leading private equity investor in the European mid-market with offices in London, Manchester, Paris, Düsseldorf and Stockholm. Montagu's Warsaw office, covering the Central and Eastern European markets, is to be launched in 2009. Over the last 40 years the firm has supported more than 400 businesses operating across a range of different segments and sectors, and currently has just under €3 billion of funds and assets under management. Montagu is focused on investing in management buyouts in partnership with the incumbent management team. The firm has a strong track record of delivering superior returns over time, an extensive network of contacts and offers its portfolio companies capital, financial expertise and strategic assistance in order to unleash their full development and growth potential. Visit www.montagu.com for more information.
